![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 28, 25273-25276, July 12, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§¶,
,
,
,
,
, and
**
From the
Instituto de Tecnologia Química e
Biológica, Universidade Nova de Lisboa, APT 127, 2780-156 Oeiras,
Portugal, the § Departamento de Química, Faculdade
de Ciências e Tecnologia, Universidade Nova de Lisboa,
2825-114 Caparica, Portugal, and the
Department of Biochemical
Sciences and CNR Centre of Molecular Biology, University of Rome "La
Sapienza," Rome S00185, Italy
Received for publication, April 22, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Escherichia coli flavorubredoxin is a
member of the family of the A-type flavoproteins, which are built by
two core domains: a metallo- Nitric oxide (NO) plays a key role in a wide variety of
physiological and pathological processes in eukaryotes, notably cell signaling and host-pathogen responses. In prokaryotes, NO is
encountered as an intermediate in the global nitrogen cycle, namely in
the process of denitrification, i.e. reduction of
nitrate/nitrite to N2. Prokaryotes not directly involved in
these metabolic pathways may nevertheless be exposed to high fluxes of
NO, produced either abiotically or biotically (for example by
macrophages (1)). In denitrifying bacteria, NO is reduced to
N2O by nitric-oxide reductase
(NOR),1 a membrane-bound
enzyme containing at the catalytic subunit a heme
b3-FeB binuclear center (2, 3). NORs
have been proposed to be evolutionarily related to the large family of
heme-copper oxygen reductases on the basis of structural homologies (4, 5); consistently, two prokaryotic oxidases were recently reported to be
endowed with NO reductase activity (6, 7). So far, only a second type
of nitric-oxide reductase belonging to the cytochrome P450 family has
been found in fungi (2).
The A-type flavoproteins are a large family of enzymes, widespread
among Bacteria and Archaea, either strict or facultative anaerobes (8,
9). The major distinctive feature of this large family is the common
core unit, built by two independent structural modules: the N-terminal
one characterized by a The recombinant enzyme from E. coli (named flavorubredoxin,
FlRd), purified and characterized, was shown to contain one
rubredoxin-like center, one FMN, and one di-iron center. It was further
shown that indeed it receives electrons from the NADH:oxidoreductase (FlRd-red) encoded in the same gene locus (22). As for the enzyme from
D. gigas, it was also proven that FlRd is able to reduce O2 to water; moreover, the di-iron center was shown to bind
NO (22). Recently, Gardner et al. (23) reported that
E. coli grown anaerobically and exposed (for a certain
period of time) to NO develops a NO reductase activity, which is lost
by knocking out the gene encoding for FlRd. However, the same authors
were unable to show that the flavorubredoxin is responsible for NO reduction, attributing this failure to enzyme instability. In this
article, we show that recombinant E. coli flavorubredoxin is
a NO reductase, with a turnover number (14.9 ± 6.7 mol of
NO·mol FlRd Protein Expression and Purification--
Recombinant FlRd and
FlRd-red were expressed and purified as described previously (8, 22).
Amplification of the Rd domain of E. coli FlRd was achieved
by means of a PCR reaction using Pfu polymerase
(Stratagene), the recombinant plasmid pME2543 (that contains the
complete E. coli orf479 (8)), and the following oligonucleotides: sense primer, (5'-GCTCATATGGGCCCACGGAT-3'), which
introduced a NdeI site changing the codon of the residue 422 to the initiation codon ATG, and antisense primer, T7 22-mer (5'-GTAATACGACTCACTATAGGGC-3'). The amplicon was digested with NdeI and HindIII, ligated into compatible sites
on pT7-7 (24), and transformed into E. coli DH5
Total protein was determined using the BCA procedure (26) and iron
quantitated by the TPTZ (2,4,6-tripyridyl-1,3,5-triazine) method
(27). Total FMN content of FlRd was assessed after protein denaturation
with 8% trichloroacetic acid, using an extinction coefficient
of 12500 M Kinetic Assays--
Nitric oxide consumption measurements were
carried out using a World Precision Instruments ISO-NOP 2 mm electrode,
at room temperature. Assays were carried out under anaerobic conditions in 50 mM Tris-HCl buffer at pH = 7.6, in the presence
of EDTA (20 µM), glucose (3 mM), glucose
oxidase (4 units/ml), and catalase (130 units/ml). Oxygen consumption
rates were measured using a Yellow Springs micro-O2
electrode, in 50 mM Tris-HCl buffer at pH 7.6 and room temperature.
Flavorubredoxin Is a Novel NO Reductase with High Affinity for
NO--
The NO reductase activity of E. coli FlRd was
investigated measuring NO consumption in the presence of the
physiological partner, FlRd reductase, and NADH. It was observed that
FlRd catalyzes efficiently the NO consumption (Fig.
1); the rate of 14.9 ± 6.7 mol of
NO·mol FlRd
Control experiments showed that the observed NO consumption is
exclusively attributable to FlRd-mediated catalysis: (i) in the absence of FlRd, NO consumption mediated by the NADH/FlRd-red pair
was much lower (even at different FlRd-red concentrations) than in the
presence of FlRd; (ii) FlRd denaturation by boiling the protein for 10 min in the presence of 10% SDS totally abolishes NO consumption, thus
excluding that contaminant inorganic compounds in the medium are
responsible for the observed NO degradation. Altogether, these results
clearly establish that E. coli FlRd operates as a bona
fide NOR, with a measured turnover number comparable with that
published for NOR from P. denitrificans (in the range ~10-50 mol of NO·mol NOR The Di-iron Cluster Is the Active Site--
The E. coli
FlRd contains two different metal centers, integrated into distinct
structural domains: the rubredoxin (Rd) center in a rubredoxin-like
fold and the non-heme di-iron site. Several evidences show that the
di-iron center is the site of NO reduction in FlRd. We previously
observed by EPR spectroscopy that the di-iron center of FlRd is able to
bind NO (22). In this work we have tested a truncated form of FlRd,
consisting solely of the rubredoxin domain, that proved to be unable to
process NO (data not shown), despite being still efficiently reduced by
the NADH/FlRd-reductase couple.2 Furthermore, the NO
reductase activity is not inhibited by cyanide (even after 1-day
incubation, both at 4 °C or at room temperature, and 3 mM cyanide), which is consistent with the fact that the di-iron site has low affinity for cyanide.
Flavorubredoxin Is a Bifunctional NO and O2 Reductase,
albeit with Distinct Affinities--
The FlRd di-iron site is capable
of reducing O2 to water, in the presence of NADH and
FlRd-red (22). Within experimental errors, the NO and O2
consumption rates are similar (Fig. 2), as estimated from the initial
rate at high O2 concentration, i.e. in
air-equilibrated buffer. NO and O2 consumption may be thus rate-limited by the same event (for instance by internal electron transfer to the di-iron site). However, whereas NO is processed with a
high affinity, O2 reduction does not follow a zero-order kinetics, as the apparent rate starts to slow down at ~200
µM O2. This points to a relatively low
affinity for O2, compared with the much higher affinity for
NO (Km < 1 µM). It is interesting
that a similar observation has been described for the P. denitrificans NOR (see Fig. 7 in Ref. 28).
The results reported in this article demonstrate that in
vitro E. coli FlRd has NO reductase activity,
comparable with that of canonical heme
b3-FeB containing NORs. Although at
this stage it was not possible to measure this activity in other A-type
flavoproteins, the large overall similarity in amino acid sequence
among most members of this family, and the conservation of residues
binding the di-iron site (29) strongly suggests that the NO reductase activity will be found in many other (if not all) A-type flavoproteins. These enzymes seem therefore to display a bifunctional activity, in so
far as they are also able to catalyze the reduction of O2 to water. In this respect we notice a similarity between the
heme-copper oxygen reductases and the NO reductases, providing evidence
for a widespread bifunctional versatility in the prokaryotic response to environmental conditions, notably detoxification of O2
or NO.
This enzyme family is present in a large variety of prokarytotes,
phylogenetically and metabolically as diverse as hyperthermophilic anaerobic archaea (such as Pyrococcus species,
e.g. Ref. 30), strict and facultative anaerobic bacteria
(including enterobacteria, ((19, 20)), photosynthetic cyanobacteria
(16, 17), nitrogen-fixing organisms (such as R. capsulatus
(12)), sulfate-reducing archaea (31) and bacteria (11, 15), and
Clostridia species (21, 32) (Fig.
3). The genomic organization
of the A-type flavoproteins is however quite diversified. In fact,
among the known genomes, only enterobacteria have a genomic
organization, whereby the gene encoding for the FlRd is adjacent to
that encoding for its reductase (18, 22), and both are close to a
putative NO regulator (23). In other microorganisms, the genes encoding
for A-type flavoproteins are close to sequences encoding for quite
diverse or still unknown proteins. Especially interesting cases are
those found in the genomes of C. perfringens (21) and
acetobutylicum (32), Methanobacterium thermoautrophicum (33), Methanococcus jannaschii (34),
Pyrococcus horikoshi (30), and Moorella
thermoacetica (35), in which the A-type flavoproteins are in
clusters containing genes coding for proteins involved in oxidative
stress responses, such as alkyl hydroperoxide reductases, superoxide
reductases, or superoxide dismutases. Thus, although there is no simple
and direct correlation between the genomic organization of these
enzymes and their physiological functions, examination of the available
gene clusters suggests strong physiological links between
O2 and NO metabolisms. Furthermore, while in organisms such
as D. gigas, R. capsulatus, and M. thermoautotrophicum, the A-type flavoproteins are expressed
constitutively under sulfate-reducing, nitrogen-fixing, and
methanogenic growth conditions, respectively, in E. coli the
FlRd endowed with NO reductase activity were proposed to be induced by
exposure to NO (23).
-lactamase-like domain, at the
N-terminal region, harboring a non-heme di-iron site, and a
flavodoxin-like domain, containing one FMN moiety. The enzyme from
E. coli has an extra module at the C terminus, containing a
rubredoxin-like center. The A-type flavoproteins are widespread among
strict and facultative anaerobes, as deduced from the analysis of the
complete prokaryotic genomes. In this report we showed that the
recombinant enzyme purified from E. coli has nitric-oxide
reductase activity with a turnover number of ~15 mol of NO·mol
enzyme
1·s
1, which was well within the
range of those determined for the canonical heme
b3-FeB containing nitric-oxide
reductases (e.g. ~10-50 mol NO·mol
enzyme
1·s
1 for the Paracoccus
denitrificans NOR). Furthermore, it was shown that the activity
was due to the A-type flavoprotein core, as the rubredoxin domain alone
exhibited no activity. Thus, a novel family of prokaryotic NO
reductases, with a non-heme di-iron site as the catalytic center, was established.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSIONS
REFERENCES
-lactamase-like fold and the second domain,
having a short chain flavodoxin-like fold (10). Only a few members of
this family have been so far purified from its natural host: the
enzymes from Desulfovibrio gigas (11), Rhodobacter
capsulatus (12), and Methanobacterium thermoautotrophicum (13). The first to be extensively
studied was the rubredoxin:oxygen oxidoreductase from the
sulfate-reducing bacterium D. gigas. This enzyme reduces
O2 to water receiving electrons from a type-I rubredoxin,
which in turn is reduced by an NADH:rubredoxin oxidoreductase (14). The
three-dimensional crystal structure of rubredoxin:oxygen oxidoreductase
(10) revealed its modular architecture and, quite strikingly, showed
that the
-lactamase domain harbors a non-heme di-iron site,
consistent with the O2 reductase activity of this enzyme.
The flavodoxin domain contains one FMN molecule, which receives
electrons from the rubredoxin (15). The homologous enzymes from
cyanobacteria Synechocystis (8, 16) and Anabaena
(17), from enterobacteria (E. coli (18),
Salmonella enterica serovar Typhimurium LT2 (19), and
S. enterica serovar Typhi CT18 (20)), and from
Clostridium perfringens (21) contain one extra domain at the
C terminus; whereas the cyanobacterial enzymes contain one
NADH:oxidoreductase domain (condensing into a single protein the
complete electron transfer chain from NADH to O2), the
enterobacterial enzymes have a rubredoxin-like domain (Rd),
i.e. they bear the direct electron donor fused to the core
catalytic domain. Interestingly, in these enterobacteria, downstream
from the gene encoding for the A-type flavoprotein, there is a gene
encoding for a NADH:rubedoxin oxidoreductase, with both genes possibly
forming a dicistronic transcriptional unit.
1·s
1) similar to that of
canonical heme b3-FeB containing NOR enzymes (2, 3). Thus we demonstrate the existence of a novel family of NO
reductases, which is likely to be widespread among strict and
facultative anaerobes.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSIONS
REFERENCES
cells.
The cloned insert was then sequenced in both strands by using
vector-specific oligonucleotide primers and fluorescent dideoxy
terminators and an ABI model 377 DNA sequencer. After confirming that
the correct nucleotide sequence was amplified, the recombinant plasmid
was transformed in BL21-Gold(DE3). Overnight cultures, grown
aerobically at 37 °C in minimal medium M9 (24) containing ampicilin
(100 µg/ml), were diluted 1/100 into the same medium, grown to an
A600 of 0.8, induced with 0.4 mM
isopropyl-1-thio-
-D-galactopyranoside, and
harvested by centrifugation after 4 h. After cell disruption in a
French press at 7000 p.s.i. (in two cycles), and soluble extract
separation from the membranes through 16-h ultracentrifugation at
100,000 × g (at 5 °C), the rubredoxin domain of
flavorubredoxin was purified in a two-step procedure, in a HiLoad
Pharmacia system. The soluble extract was dialyzed overnight against 10 mM Tris-HCl, pH 7.6 (buffer A), and then loaded into a
60-ml Q-Sepharose column previously equilibrated with buffer A. The
rubredoxin domain of flavorubredoxin eluted at ~400 mM
NaCl was concentrated in a Diaflo cell with a YM3 cutoff membrane and
further applied to a Superdex S-75 gel filtration column, previously
equilibrated with 150 mM NaCl in buffer A. The eluted
protein was found to be pure, as assayed by SDS-gel electrophoresis
(25).
1·cm
1 at
= 450 nm to quantify the flavin. Recombinant FlRd was found to contain 1 mol of flavin/mol of protein and ~3.3 mol of iron/mol of protein,
while FlRd reductase contained 1 mol of FAD/mol of protein, and the
FlRd rubredoxin domain contained 1 mol of iron/mol of protein. The
detailed characterization of the rubredoxin domain will be published elsewhere.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSIONS
REFERENCES
1·s
1 was estimated by
averaging 26 independent measurements carried out at different
concentrations of FlRd-red (Fig. 2) and
at saturating NADH concentration (> 200 µM). The
activity is linearly dependent on FlRd concentration, but is
essentially independent of NO concentration from
1 µM
(approximately the physiological levels) to ~10 µM. This shows that the enzyme has high affinity for NO
(Km < 1 µM), consistent with the
zero-order kinetics of the observed NO consumption (Fig. 1).

View larger version (9K):
[in a new window]
Fig. 1.
NO reductase activity of E. coli FlRd. To an anaerobic buffer, containing 2.6 µM FlRd-red, three aliquots of NO (yielding a final
concentration of 6.8 µM) were sequentially added. After
raising the chart speed, 1 mM NADH was added. Following the
addition of 22.5 nM FlRd at about 4.7 µM NO,
a fast consumption of NO was observed whose time course followed a
zero-order kinetics. Analysis of this trace yields a NO reductase
activity for FlRd corresponding to 14.6 mol of NO·mol
FlRd
1·s
1.

View larger version (14K):
[in a new window]
Fig. 2.
E. coli FlRd is a bifunctional NO
and O2 reductase. O2 and NO reductase
activity of E. coli FlRd (7.5 or 22.5 nM) were
measured in the presence of NADH (>200 µM), at
increasing concentration of FlRd-reductase. NO consumption was measured
at [NO] = 1
10 µM, whereas O2
consumption was estimated from initial rate at high [O2],
i.e. in air-equilibrated buffer.
1·s
1 (2,
3)).
![]()
CONCLUSIONS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
CONCLUSIONS
REFERENCES

View larger version (23K):
[in a new window]
Fig. 3.
Distribution of A-type flavoproteins among
prokaryotes. Schematic representation of the 16 S RNA tree of
life, showing the presence of A-type flavoproteins among bacterial and
archaeal groups. Gray shaded boxes,
Archaeoglobales (e.g. Archaeoglobus
fulgidus), Methanobacteriales (e.g. M. thermoautotrophicum), Methanococcales (e.g.
M. jannaschii), Thermococcales (e.g.
Pyrococcus furiosus), Thermotogales
(e.g. Thermotoga maritima),
Bacteroidales (e.g. Porphyromonas
gingivales), Cyanobacteria (e.g. Synechocystis
sp.), Purple bacteria (e.g. the proteobacteria E. coli, Salmonella thyphimurium, D. gigas),
Gram-positive bacteria (e.g. C. perfringens).
In summary, we have shown that the purified recombinant E. coli A-type flavoprotein has a high NO reductase activity, which allows to propose a novel family of NO reducing enzymes that may play a
key role in NO detoxification by prokaryotes. The relationships between
the two functions of this family related to NO and O2 detoxification, and the understanding of the intricate regulation of
the expression and activities of these enzymes, are challenges for the
near future.
| |
ACKNOWLEDGEMENTS |
|---|
We thank our co-workers who have contributed to the understanding of this protein family and Paolo Sarti (Rome, Italy) for the critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by Grant POCTI-36558/FCT (to M. T.), Bolsa de Iniciação à Investigação Grant 044/BIC/2001 (to J. B. V.), and by the Ministero dell'Istruzione, dell'Università e della Ricerca of Italy (Centro di Eccellenza "Biologia e Medicina Molecolare") (to M. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ These authors contributed equally to this work.
** To whom correspondence should be addressed: Inst. de Tecnologia Química e Biológica, Universidade Nova de Lisboa, APT 127, 2780-156 Oeiras, Portugal. Tel.: 351-21-446-9847; Fax: 351-21-442-8766; E-mail: miguel@itqb.unl.pt.
Published, JBC Papers in Press, May 6, 2002, DOI 10.1074/jbc.M203886200
2 C. M. Gomes, J. B. Vicente, L. M. Saraiva, and M. Teixeira, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: NOR, nitric-oxide reductase; FlRd, flavorubredoxin; FlRd-red, flavorubredoxin-reductase; Rd, rubredoxin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | MacMicking, J., Xie, Q. W., and Nathan, C. (1997) Annu. Rev. Immunol. 15, 323-350[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Zumft, W. G. (1997) Microbiol. Mol. Biol. Rev. 61, 533-616[Abstract] |
| 3. | Hendriks, J., Warne, A., Gohlke, U., Haltia, T., Ludovici, C., Lubben, M., and Saraste, M. (1998) Biochemistry 37, 13102-13109[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Saraste, M., and Castresana, J. (1994) FEBS Lett. 341, 1-4[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | van der Oost, J., de Boer, A. P., de Gier, J. W., Zumft, W. G., Stouthamer, A. H., and van Spanning, R. J. (1994) FEMS Microbiol. Lett. 121, 1-9[Medline] [Order article via Infotrieve] |
| 6. |
Giuffre, A.,
Stubauer, G.,
Sarti, P.,
Brunori, M.,
Zumft, W. G.,
Buse, G.,
and Soulimane, T.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14718-14723 |
| 7. | Forte, E., Urbani, A., Saraste, M., Sarti, P., Brunori, M., and Giuffre, A. (2001) Eur J Biochem. 268, 6486-6491[Medline] [Order article via Infotrieve] |
| 8. | Wasserfallen, A., Ragettli, S., Jouanneau, Y., and Leisinger, T. (1998) Eur. J. Biochem. 254, 325-332[Medline] [Order article via Infotrieve] |
| 9. | Gomes, C. M., Teixeira, M., and Wasserfallen, A. (1999) in Flavins and Flavoproteins (Ghisla, S. , Krömeck, P. , Macheroux, P. , and Sund, H., eds) , pp. 219-222, Rudolf Weber-Agency for Scientific Publications, Berlin |
| 10. | Frazão, C., Silva, G., Gomes, C. M., Matias, P., Coelho, R., Sieker, L., Macedo, S., Liu, M. Y., Oliveira, S., Teixeira, M., Xavier, A. V., Rodrigues-Pousada, C., Carrondo, M. A., and Le Gall, J. (2000) Nat. Struct. Biol. 7, 1041-1045[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Chen, L., Liu, M. Y., LeGall, J., Fareleira, P., Santos, H., and Xavier, A. V. (1993) Biochem. Biophys. Res. Commun. 193, 100-105[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Jouanneau, Y., Meyer, C., Asso, M., Guigliarelli, B., and Willison, J. C. (2000) Eur. J. Biochem. 267, 780-787[Medline] [Order article via Infotrieve] |
| 13. |
Wasserfallen, A.,
Huber, K.,
and Leisinger, T.
(1995)
J. Bacteriol.
177,
2436-2441 |
| 14. | Chen, L., Liu, M. Y., Legall, J., Fareleira, P., Santos, H., and Xavier, A. V. (1993) Eur. J. Biochem. 216, 443-448[Medline] [Order article via Infotrieve] |
| 15. |
Gomes, C. M.,
Silva, G.,
Oliveira, S.,
LeGall, J.,
Liu, M. Y.,
Xavier, A. V.,
Rodrigues-Pousada, C.,
and Teixeira, M.
(1997)
J. Biol. Chem.
272,
22502-22508 |
| 16. | Kaneko, T., Tanaka, A., Sato, S., Kotani, H., Sazuka, T., Miyajima, N., Sugiura, M., and Tabata, S. (1995) DNA Res. 2, 153-166[Abstract], 191-198 |
| 17. | Kaneko, T., Nakamura, Y., Wolk, C. P., Kuritz, T., Sasamoto, S., Watanabe, A., Iriguchi, M., Ishikawa, A., Kawashima, K., Kimura, T., Kishida, Y., Kohara, M., Matsumoto, M., Matsuno, A., Muraki, A., Nakazaki, N., Shimpo, S., Sugimoto, M., Takazawa, M., Yamada, M., Yasuda, M., and Tabata, S. (2001) DNA Res. 8, 205-213[Abstract] |
| 18. |
Blattner, F. R.,
Plunkett, G., III,
Bloch, C. A.,
Perna, N. T.,
Burland, V.,
Riley, M.,
Collado-Vides, J.,
Glasner, J. D.,
Rode, C. K.,
Mayhew, G. F.,
Gregor, J.,
Davis, N. W.,
Kirkpatrick, H. A.,
Goeden, M. A.,
Rose, D. J.,
Mau, B.,
and Shao, Y.
(1997)
Science
277,
1453-1474 |
| 19. | McClelland, M., Sanderson, K. E., Spieth, J., Clifton, S. W., Latreille, P., Courtney, L., Porwollik, S., Ali, J., Dante, M., Du, F., Hou, S., Layman, D., Leonard, S., Nguyen, C., Scott, K., Holmes, A., Grewal, N., Mulvaney, E., Ryan, E., Sun, H., Florea, L., Miller, W., Stoneking, T., Nhan, M., Waterston, R., and Wilson, R. K. (2001) Nature 413, 852-856[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Parkhill, J., Dougan, G., James, K. D., Thomson, N. R., Pickard, D., Wain, J., Churcher, C., Mungall, K. L., Bentley, S. D., Holden, M. T., Sebaihia, M., Baker, S., Basham, D., Brooks, K., Chillingworth, T., Connerton, P., Cronin, A., Davis, P., Davies, R. M., Dowd, L., White, N., Farrar, J., Feltwell, T., Hamlin, N., Haque, A., Hien, T. T., Holroyd, S., Jagels, K., Krogh, A., Larsen, T. S., Leather, S., Moule, S., O'Gaora, P., Parry, C., Quail, M., Rutherford, K., Simmonds, M., Skelton, J., Stevens, K., Whitehead, S., and Barrell, B. G. (2001) Nature 413, 848-852[CrossRef][Medline] [Order article via Infotrieve] |
| 21. |
Shimizu, T.,
Ohtani, K.,
Hirakawa, H.,
Ohshima, K.,
Yamashita, A.,
Shiba, T.,
Ogasawara, N.,
Hattori, M.,
Kuhara, S.,
and Hayashi, H.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
996-1001 |
| 22. | Gomes, C. M., Vicente, J. B., Wasserfallen, A., and Teixeira, M. (2000) Biochemistry 39, 16230-16237[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Gardner, A. M.,
Helmick, R. A.,
and Gardner, P. R.
(2002)
J. Biol. Chem.
277,
8172-8177 |
| 24. | Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1995) Current Protocols in Molecular Biology , Greene Publishing Associates and Wiley-Interscience, New York |
| 25. | Garfin, D. E. (1990) Methods Enzymol. 182, 425-441[Medline] [Order article via Infotrieve] |
| 26. | Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Anal. Biochem. 150, 76-85[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Fischer, D. S., and Price, D. C. (1964) Clin. Chem. 10, 21-25[Abstract] |
| 28. |
Fujiwara, T.,
and Fukumori, Y.
(1996)
J. Bacteriol.
178,
1866-1871 |
| 29. |
Gomes, C. M.,
Frazao, C.,
Xavier, A. V.,
Legall, J.,
and Teixeira, M.
(2002)
Protein Sci.
11,
707-712 |
| 30. | Kawarabayasi, Y., Sawada, M., Horikawa, H., Haikawa, Y., Hino, Y., Yamamoto, S., Sekine, M., Baba, S., Kosugi, H., Hosoyama, A., Nagai, Y., Sakai, M., Ogura, K., Otsuka, R., Nakazawa, H., Takamiya, M., Ohfuku, Y., Funahashi, T., Tanaka, T., Kudoh, Y., Yamazaki, J., Kushida, N., Oguchi, A., Aoki, K., and Kikuchi, H. (1998) DNA Res. 5, 55-76[Abstract] |
| 31. | Klenk, H. P., Clayton, R. A., Tomb, J. F., White, O., Nelson, K. E., Ketchum, K. A., Dodson, R. J., Gwinn, M., Hickey, E. K., Peterson, J. D., Richardson, D. L., Kerlavage, A. R., Graham, D. E., Kyrpides, N. C., Fleischmann, R. D., Quackenbush, J., Lee, N. H., Sutton, G. G., Gill, S., Kirkness, E. F., Dougherty, B. A., McKenney, K., Adams, M. D., Loftus, B., Venter, J. C., et al.. (1997) Nature 390, 364-370[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Nolling, J.,
Breton, G.,
Omelchenko, M. V.,
Makarova, K. S.,
Zeng, Q.,
Gibson, R.,
Lee, H. M.,
Dubois, J.,
Qiu, D.,
Hitti, J.,
Wolf, Y. I.,
Tatusov, R. L.,
Sabathe, F.,
Doucette-Stamm, L.,
Soucaille, P.,
Daly, M. J.,
Bennett, G. N.,
Koonin, E. V.,
and Smith, D. R.
(2001)
J. Bacteriol.
183,
4823-4838 |
| 33. |
Smith, D. R.,
Doucette-Stamm, L. A.,
Deloughery, C.,
Lee, H.,
Dubois, J.,
Aldredge, T.,
Bashirzadeh, R.,
Blakely, D.,
Cook, R.,
Gilbert, K.,
Harrison, D.,
Hoang, L.,
Keagle, P.,
Lumm, W.,
Pothier, B.,
Qiu, D.,
Spadafora, R.,
Vicaire, R.,
Wang, Y.,
Wierzbowski, J.,
Gibson, R.,
Jiwani, N.,
Caruso, A.,
Bush, D.,
Reeve, J. N.,
et al..
(1997)
J. Bacteriol.
179,
7135-7155 |
| 34. | Bult, C. J., White, O., Olsen, G. J., Zhou, L., Fleischmann, R. D., Sutton, G. G., Blake, J. A., FitzGerald, L. M., Clayton, R. A., Gocayne, J. D., Kerlavage, A. R., Dougherty, B. A., Tomb, J. F., Adams, M. D., Reich, C. I., Overbeek, R., Kirkness, E. F., Weinstock, K. G., Merrick, J. M., Glodek, A., Scott, J. L., Geoghagen, N. S., and Venter, J. C. (1996) Science 273, 1058-1073[Abstract] |
| 35. |
Das, A.,
Coulter, E. D.,
Kurtz, D. M., Jr.,
and Ljungdahl, L. G.
(2001)
J. Bacteriol.
183,
1560-1567 |
This article has been cited by other articles:
![]() |
J. H. van Wonderen, B. Burlat, D. J. Richardson, M. R. Cheesman, and J. N. Butt The Nitric Oxide Reductase Activity of Cytochrome c Nitrite Reductase from Escherichia coli J. Biol. Chem., April 11, 2008; 283(15): 9587 - 9594. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Mills, G. Rowley, S. Spiro, J. C. D. Hinton, and D. J. Richardson A combination of cytochrome c nitrite reductase (NrfA) and flavorubredoxin (NorV) protects Salmonella enterica serovar Typhimurium against killing by NO in anoxic environments Microbiology, April 1, 2008; 154(4): 1218 - 1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Sievert, K. M. Scott, M. G. Klotz, P. S. G. Chain, L. J. Hauser, J. Hemp, M. Hugler, M. Land, A. Lapidus, F. W. Larimer, et al. Genome of the Epsilonproteobacterial Chemolithoautotroph Sulfurimonas denitrificans Appl. Envir. Microbiol., February 15, 2008; 74(4): 1145 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Di Matteo, F. M. Scandurra, F. Testa, E. Forte, P. Sarti, M. Brunori, and A. Giuffre The O2-scavenging Flavodiiron Protein in the Human Parasite Giardia intestinalis J. Biol. Chem., February 15, 2008; 283(7): 4061 - 4068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Pullan, M. D. Gidley, R. A. Jones, J. Barrett, T. M. Stevanin, R. C. Read, J. Green, and R. K. Poole Nitric Oxide in Chemostat-Cultured Escherichia coli Is Sensed by Fnr and Other Global Regulators: Unaltered Methionine Biosynthesis Indicates Lack of S Nitrosation J. Bacteriol., March 1, 2007; 189(5): 1845 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-S. Bang, L. Liu, A. Vazquez-Torres, M.-L. Crouch, J. S. Stamler, and F. C. Fang Maintenance of Nitric Oxide and Redox Homeostasis by the Salmonella Flavohemoglobin Hmp J. Biol. Chem., September 22, 2006; 281(38): 28039 - 28047. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rodrigues, J. B. Vicente, R. Felix, S. Oliveira, M. Teixeira, and C. Rodrigues-Pousada Desulfovibrio gigas Flavodiiron Protein Affords Protection against Nitrosative Stress In Vivo. J. Bacteriol., April 1, 2006; 188(8): 2745 - 2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Hamilton-Brehm, G. J. Schut, and M. W. W. Adams Metabolic and Evolutionary Relationships among Pyrococcus Species: Genetic Exchange within a Hydrothermal Vent Environment J. Bacteriol., November 1, 2005; 187(21): 7492 - 7499. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Vicente and M. Teixeira Redox and Spectroscopic Properties of the Escherichia coli Nitric Oxide-detoxifying System Involving Flavorubredoxin and Its NADH-oxidizing Redox Partner J. Biol. Chem., October 14, 2005; 280(41): 34599 - 34608. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Arai, M. Hayashi, A. Kuroi, M. Ishii, and Y. Igarashi Transcriptional Regulation of the Flavohemoglobin Gene for Aerobic Nitric Oxide Detoxification by the Second Nitric Oxide-Responsive Regulator of Pseudomonas aeruginosa J. Bacteriol., June 15, 2005; 187(12): 3960 - 3968. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brunori, A. Giuffre, K. Nienhaus, G. U. Nienhaus, F. M. Scandurra, and B. Vallone Neuroglobin, nitric oxide, and oxygen: Functional pathways and conformational changes PNAS, June 14, 2005; 102(24): 8483 - 8488. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Flatley, J. Barrett, S. T. Pullan, M. N. Hughes, J. Green, and R. K. Poole Transcriptional Responses of Escherichia coli to S-Nitrosoglutathione under Defined Chemostat Conditions Reveal Major Changes in Methionine Biosynthesis J. Biol. Chem., March 18, 2005; 280(11): 10065 - 10072. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Justino, J. B. Vicente, M. Teixeira, and L. M. Saraiva New Genes Implicated in the Protection of Anaerobically Grown Escherichia coli against Nitric Oxide J. Biol. Chem., January 28, 2005; 280(4): 2636 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Busch, A. Pohlmann, B. Friedrich, and R. Cramm A DNA Region Recognized by the Nitric Oxide-Responsive Transcriptional Activator NorR Is Conserved in {beta}- and {gamma}-Proteobacteria J. Bacteriol., December 1, 2004; 186(23): 7980 - 7987. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cabello, M. D. Roldan, and C. Moreno-Vivian Nitrate reduction and the nitrogen cycle in archaea Microbiology, November 1, 2004; 150(11): 3527 - 3546. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Tucker, B. D'Autreaux, D. J. Studholme, S. Spiro, and R. Dixon DNA Binding Activity of the Escherichia coli Nitric Oxide Sensor NorR Suggests a Conserved Target Sequence in Diverse Proteobacteria J. Bacteriol., October 1, 2004; 186(19): 6656 - 6660. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Missall, J. K. Lodge, and J. E. McEwen Mechanisms of Resistance to Oxidative and Nitrosative Stress: Implications for Fungal Survival in Mammalian Hosts Eukaryot. Cell, August 1, 2004; 3(4): 835 - 846. [Full Text] [PDF] |
||||
![]() |
A. M. Gardner, C. R. Gessner, and P. R. Gardner Regulation of the Nitric Oxide Reduction Operon (norRVW) in Escherichia coli. ROLE OF NorR AND sigma 54 IN THE NITRIC OXIDE STRESS RESPONSE J. Biol. Chem., March 14, 2003; 278(12): 10081 - 10086. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||